Argireline Research Guide

Full name: Argireline (Acetyl Hexapeptide-3)

A synthetic hexapeptide that mimics SNAP-25 protein. Often called "topical Botox," it reduces expression lines by inhibiting neurotransmitter release at neuromuscular junctions.

How Argireline Works

Competes with SNAP-25 for position in SNARE complex, partially inhibiting vesicle docking and neurotransmitter release, reducing muscle contraction intensity.

Dosing Protocol

• Typical dose: 5-10% solution
• Frequency: 2x daily
• Duration: 4-8 weeks for initial results
• Route: Topical

Reported Benefits

• Reduces expression wrinkles up to 30%
• Non-invasive Botox alternative
• Prevents new wrinkle formation
• No muscle paralysis
• Stackable with other peptides

Potential Side Effects

• Mild tingling
• Rare skin sensitivity

Research Citations

1. Efficacy of acetyl hexapeptide-8 on facial wrinkles (2021) - 10% argireline reduced wrinkle depth around eyes by 30% after 30 days of twice-daily application.
2. SNARE complex modulation by hexapeptide-8 (2019) - Inhibited catecholamine release by 40% in chromaffin cells by competing with SNAP-25.

Related Skin & Anti-Aging Compounds

• Copper Peptides - Full Profile
• Matrixyl - Full Profile
• Leuphasyl - Full Profile
• SNAP-8 - Full Profile
• Palmitoyl Tripeptide-1 - Full Profile
• Palmitoyl Tetrapeptide-7 - Full Profile

View full Argireline profile with 3D molecule viewer →